Ibáñez, SebastiánMorales Murillo, LuisRivera Vergara, Matías de laSaldías Martínez, Roberto2024-06-142024-06-142022BMJ Case Rep. 2022 Aug 26;15(8)https://hdl.handle.net/11447/9095A woman in her 60s with a history of adult-onset Still's disease (AOSD) in remission for 14 years received the ChAdOx1-S vaccine as a booster to her initial vaccination schedule (two doses of CoronaVac vaccine 6 months apart). Two weeks later, she consulted for symptoms suggestive of AOSD reactivation. This was confirmed during hospitalisation, where renal and cardiac involvement were also observed. Despite using high-dose corticosteroids, troponin T and N-terminal pro hormone B-type natriuretic peptide (NT-proBNP) were persistently elevated. Tocilizumab was used, with which the patient achieved complete remission of her symptoms and normalised her laboratory tests.3 p.enAtribución-NoComercial-CompartirIgual 3.0 Chile (CC BY-NC-SA 3.0 CL)COVID-19Connective tissue diseaseArticlehttps://doi.org/10.1016/j.cgh.2020.10.052